How Systems are Cracking the Code on Finding the Right Patients
Evolent and Health ForumWATCH NOW
Event Date: Wednesday, September 6, 2017, 2 - 3 p.m. Eastern (1 - 2 p.m. Central)
Clinical value is at the heart of success in value-based care. As the transition to value continues to accelerate, health system and physician group success will largely be driven by an ability to consistently deliver high-quality care at a lower relative cost.
Population health is the strategy of choice for provider organizations hoping to generate clinical value. Despite the noble ambitions of population health investments, results vary greatly from one organization to the next. Why is this?
Through Evolent’s experience working across over 30 US health care markets they found that one of the key determinants of an organization’s success is their ability to focus on “impactable” patients. Impactable patients have a high likelihood of a future avoidable event, a high likelihood to engage with support resources, and a high likelihood to benefit from a pre-defined intervention.
What You Will Learn
- The key tenets of “impactability” that have been developed through value-based care work in over 30 health care markets
- The concepts that led to successful quality and cost outcomes across a variety of Evolent clients
- How to put these concepts into practice
Each session will kick off with the American Hospital Association’s brief overview of MACRA and the proposed changes to the CY 2018 quality payment program (QPP) for physicians and other eligible clinicians.
John Mach, MD
Chief Medical Officer
Dr. John Mach serves as Evolent’s Chief Medical Officer. John has 30 years of clinical and business leadership experience improving care and lowering costs for people with complex medical conditions, disabilities, advanced illness or end-of-life needs. John spent 13 years as Chief Medical Officer and CEO at Evercare, a division of UnitedHealth Group, serving frail elderly and people with disabilities. He also served as Chief Medical Officer of United’s Medicare division, Ovations. Following his UnitedHealth tenure, he was the Chief Medical Officer of XLHealth, a Medicare Duals and Chronic Illness Special Needs Plan, the President and General Manager of Complex Care Management at Univita, a national risk-bearing home care services company, and General Manager of Mach Health Care Strategies consulting practice. Prior to his service at UnitedHealth Group, John spent 10 years in clinical, academic and leadership positions in geriatric medicine at the University of Minnesota/VA Medical Center, as well as several years in private practice primary care internal medicine. John serves as a Trustee of the John A. Hartford Foundation and Board of Directors member, involving telemonitoring and caregiver ventures.
Anita Cattrell, PhD
SVP, Research and Development
As Evolent Health’s SVP of R&D, Anita leads the teams responsible for advanced analytics, new program design, and evaluation of value-based initiatives. Anita holds a PhD in Clinical Epidemiology from Harvard University and has spent that last 15 years building risk models and evaluating the impact of clinical programs for the National Institutes of Health, the Department of Defense, the Centers for Disease Control, and USAID. Prior to joining Evolent, Anita served as a Senior Associate at Booz Allen Hamilton building the firm’s Evaluation Practice and prior to that was the Director of Monitoring and Evaluation for Partners in Health, Rwanda. Anita received a BS in Biomedical Engineering from Northwestern University and a MS in Biomedical Engineering from Harvard University.
This webinar is brought to you on behalf of:WATCH NOW